Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Olympic Medical Center

The affiliation between SCCA and Olympic Medical Center means patients living on the Olympic Peninsula have access to the latest cancer treatment options, including those only available in clinical trials or at a comprehensive academic cancer center, such as SCCA.

Below are some of the SCCA clinical trials now being offered for patients at Olympic Medical Center. If you have any questions about these or other trials, please contact Olympic Medical Center.

Breast Cancer (Newly Diagnosed)

  • Chemo w/wo Traztuzumab After Surgery for Invasive Breast Cancer (NSABP B-47)
    A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab (Herceptin) in Women with Node-Positive or High-Risk Node-Negative HER@-Low Invasive Breast Cancer

Breast Cancer (Recurrent/Metastatic)

Colon Cancer (Progressive Disease)

Gynecologic Cancer (Newly Diagnosed)

Gynecologic Cancer (Recurrent/Metastatic)

  • Carboplatin + Paclitaxel w/wo Bevacizumab After Surgery (GOG 213)
    A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer